{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:24:17Z","timestamp":1792783457620,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rowan University","id":[{"id":"https:\/\/ror.org\/049v69k10","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection (CDI) is a significant healthcare-associated complication, especially for liver transplant (LT) recipients who are at increased risk due to their immuno-suppressed status and antibiotic use. This systematic review and meta-analysis aimed at elucidating the outcomes of CDI in LT recipients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We adhered to PRISMA guidelines and searched databases including CENTRAL, PubMed, Embase and Scopus until December 2024. Studies included LT recipients with and without CDI. Outcomes were pooled using meta-analytic techniques with risk ratios (RR) for dichotomous data and mean differences for continuous data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 10 included studies (1,216,500 LT recipients; 3.2% with CDI), the primary pooled analysis showed no significant difference in mortality (OR, 1.34; 95% CI, 0.38\u20134.72;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009100%). Sensitivity analyses excluding influential studies showed higher mortality in LT recipients with CDI (OR, 1.87; 95% CI, 1.45\u20132.41;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200943%). Length of stay was longer among LT recipients with CDI (mean difference, 6.00\u00a0days; 95% CI, 2.83\u20139.17;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u2009100%), with sensitivity analysis showing a mean difference of seven\u00a0days after exclusion of one study (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%). Elevated model for end-stage liver disease (MELD) scores were significantly higher in CDI cases (mean difference, 2.77; 95% CI, 1.34\u20134.20), indicating higher disease severity at baseline. Proton pump inhibitor (PPI) use was not significant in the primary pooled analysis (OR, 2.18; 95% CI, 0.29\u201316.27;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u200969%) but was significant after sensitivity analysis excluding one study (OR, 5.87; 95% CI, 2.65\u201313.03;\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In addition to a significant association between PPI use and increased risk of CDI, CDI significantly affects mortality, duration of hospital stays and pre-operative MELD scores in LT recipients, underscoring its impact on post-operative outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12664-026-02040-1","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:23Z","timestamp":1792173503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of Clostridium difficile infection in liver transplant patients: A systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Muhammad","family":"Shahzil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariha","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammad Javaid","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Hafsa","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Saad","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anza","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhaib","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimmel","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1341-3714","authenticated-orcid":false,"given":"Oasima","family":"Muner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Khaqan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed-Mohammed","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"publisher","first-page":"16020","DOI":"10.1038\/nrdp.2016.20","volume":"2","author":"WK Smits","year":"2016","unstructured":"Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2:16020.","journal-title":"Nat Rev Dis Primers"},{"key":"2040_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13020118","author":"JE Markantonis","year":"2024","unstructured":"Markantonis JE, Fallon JT, Madan R, Alam MZ. Clostridioides difficile infection: Diagnosis and treatment challenges.\u00a0Pathogens. 2024;13:118. \u00a0https:\/\/doi.org\/10.3390\/pathogens13020118.","journal-title":"Pathogens"},{"key":"2040_CR3","doi-asserted-by":"publisher","unstructured":"Di Bella S, Sanson G, Monticelli J, et al. Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options. Clin Microbiol Rev. 2024;37:e0013523. https:\/\/doi.org\/10.1128\/cmr.00135-23.","DOI":"10.1128\/cmr.00135-23"},{"issue":"1","key":"2040_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13758","volume":"24","author":"NC Kortt","year":"2022","unstructured":"Kortt NC, Santhakumar C, Davis RJ, et al. Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients. Transpl Infect Dis. 2022;24:e13758.","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/lt.23449","volume":"18","author":"M Ali","year":"2012","unstructured":"Ali M, Ananthakrishnan AN, Ahmad S, Kumar N, Kumar G, Saeian K. Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl. 2012;18:972\u20138.","journal-title":"Liver Transpl"},{"issue":"1","key":"2040_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13750","volume":"24","author":"W Amjad","year":"2022","unstructured":"Amjad W, Qureshi W, Malik A, Singh R, Jafri SM. The outcomes of Clostridioides difficile infection in inpatient liver transplant population. Transpl Infect Dis. 2022;24:e13750.","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"2040_CR7","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1097\/TP.0000000000001309","volume":"100","author":"T Sullivan","year":"2016","unstructured":"Sullivan T, Weinberg A, Rana M, Patel G, Huprikar S. The epidemiology and clinical features of Clostridium difficile infection in liver transplant recipients. Transplantation. 2016;100:1939\u201343.","journal-title":"Transplantation"},{"issue":"5","key":"2040_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00361-22","volume":"7","author":"A Gomez-Simmonds","year":"2022","unstructured":"Gomez-Simmonds A, Annavajhala MK, Nunez MP, Macesic N, Park H, Uhlemann AC. Intestinal dysbiosis and risk of posttransplant Clostridioides difficile infection in a longitudinal cohort of liver transplant recipients. mSphere. 2022;7:e00361-22.","journal-title":"mSphere"},{"issue":"6","key":"2040_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13985","volume":"24","author":"H Ali","year":"2022","unstructured":"Ali H, Patel P, Pamarthy R, Fatakhova K, Bolick NL, Satapathy SK. Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10-year national cross-sectional study. Transpl Infect Dis. 2022;24:e13985.","journal-title":"Transpl Infect Dis"},{"key":"2040_CR10","doi-asserted-by":"crossref","unstructured":"Mittal C, Hassan S, Arshad S, et al. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes. Am J Transplant. 2014;14:1901\u20137.","DOI":"10.1111\/ajt.12798"},{"issue":"6","key":"2040_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/MEG.0000000000001812","volume":"33","author":"K Wijarnpreecha","year":"2021","unstructured":"Wijarnpreecha K, Aby ES, Kim D, et al. The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission. Eur J Gastroenterol Hepatol. 2021;33:894\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"2040_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583.","journal-title":"PLoS Med"},{"key":"2040_CR13","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses.\u00a0(2000). Available online: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp#:~:text=It%20was%20developed%20to%20assess%20the%20quality%20of,quality%20assessments%20in%20the%20interpretation%20of%20meta-analytic%20results. Accessed 7 July 2026."},{"issue":"7650","key":"2040_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"2040_CR15","doi-asserted-by":"publisher","unstructured":"Rogala BG, Malat GE, Lee DH, Harhay MN, Doyle AM, Bias TE. Identification of risk factors associated with clostridium difficile infection in liver transplantation recipients: A single-center analysis. Transplant Proc. 2016;48:2763\u201368. https:\/\/doi.org\/10.1016\/j.transproceed.2016.08.006.","DOI":"10.1016\/j.transproceed.2016.08.006"},{"issue":"10","key":"2040_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1432-2277.2007.00530.x","volume":"20","author":"JB Albright","year":"2007","unstructured":"Albright JB, Bonatti H, Mendez J, et al. Early and late onset Clostridium difficile\u2010associated colitis following liver transplantation. Transplant Int. 2007;20:856\u201366.","journal-title":"Transplant Int"},{"issue":"5","key":"2040_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/ice.2018.48","volume":"39","author":"R Luo","year":"2018","unstructured":"Luo R, Weinberg JM, Barlam TF. The impact of Clostridium difficile infection on future outcomes of solid organ transplant recipients. Infect Control Hosp Epidemiol. 2018;39:563\u201370.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"suppl","key":"2040_CR18","first-page":"16","volume":"104","author":"K Harnoncourt","year":"1989","unstructured":"Harnoncourt K. Blood gases and the small airways. Wien Med Wochenschr Suppl. 1989;104 Suppl:16\u20138.","journal-title":"Wien Med Wochenschr Suppl"},{"issue":"7","key":"2040_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/lt.24139","volume":"21","author":"KR Reddy","year":"2015","unstructured":"Reddy KR, O\u2019Leary JG, Kamath PS, et al. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease. Liver Transpl. 2015;21:881\u20138.","journal-title":"Liver Transpl"},{"issue":"3","key":"2040_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.amjsurg.2020.01.022","volume":"220","author":"VM Zaydfudim","year":"2020","unstructured":"Zaydfudim VM, Turrentine FE, Smolkin ME, Bauer TB, Adams RB, McMurry TL. The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection. Am J Surg. 2020;220:682\u20136.","journal-title":"Am J Surg"},{"issue":"4","key":"2040_CR21","doi-asserted-by":"publisher","first-page":"696.e11","DOI":"10.1016\/j.jcrc.2014.03.002","volume":"29","author":"L Buendgens","year":"2014","unstructured":"Buendgens L, Bruensing J, Matthes M, et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. J Crit Care. 2014;29:696.e11\u20135.","journal-title":"J Crit Care"},{"issue":"1","key":"2040_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/gut.39.1.54","volume":"39","author":"J Thorens","year":"1996","unstructured":"Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54\u20139.","journal-title":"Gut"},{"issue":"12","key":"2040_CR23","doi-asserted-by":"publisher","first-page":"e2141089","DOI":"10.1001\/jamanetworkopen.2021.41089","volume":"4","author":"SM Hosseini-Moghaddam","year":"2021","unstructured":"Hosseini-Moghaddam SM, Luo B, Bota SE, et al. Incidence and outcomes associated with Clostridioides difficile infection in solid organ transplant recipients. JAMA Netw Open. 2021;4:e2141089.","journal-title":"JAMA Netw Open"},{"key":"2040_CR24","doi-asserted-by":"publisher","unstructured":"Brindise E, Kobeszko M, Kuruvilla A, Elkhatib I, Silva R. 1002 Clostridioides difficile Infection in Liver Transplant Recipients. Am J Gastroenterol. 2019;114:S581\u2013S581. https:\/\/doi.org\/10.14309\/01.ajg.0000593544.02292.a6","DOI":"10.14309\/01.ajg.0000593544.02292.a6"},{"key":"2040_CR25","doi-asserted-by":"crossref","unstructured":"Garg S, Wozniak A, Shoham S, Hamilton JP, Gurakar A. Clostridium difficile infection among patients who have undergone orthotropic liver transplantation. Gastroenterol. 2014;146:S\u2013942.\u00a0","DOI":"10.1016\/S0016-5085(14)63420-X"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-026-02040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-026-02040-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-026-02040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:25Z","timestamp":1792173505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-026-02040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":25,"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s12664-026-02040-1","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"15 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MS, FH, AJC, SHQ, MSF, AM, AE, SA, RA, OM, MAK and S-MJ\u00a0declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of previously published data and did not involve human participants or require ethical approval.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Human ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study does not include any individual data requiring consent for publication.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":5,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}]}}